Results 21 to 30 of about 382,024 (296)

Characteristic of fibrotic myocardial lesions associated with life-threatening ventricular tachyarrhythmias in patients with ischemic and non-ischemic cardiomyopathies [PDF]

Терапевтический архив, 2018
Aim. To identify the features of myocardial scar and fibrosis associated with the occurrence of malignant ventricular tachyarrhythmias (VTs) in high-risk patients with ischemic (ICMP) and non-ischemic cardiomyopathy (NICMP). Materials and methods.
N B Shlevkov, A A Zhambeev, A Z Gasparyan, V N Shitov, O V Stukalova   +4 more
doaj   +1 more source

Determinants of the time-to-peak left ventricular dP/dt (Td) and QRS duration with different fusion strategies in cardiac resynchronization therapy

Frontiers in Cardiovascular Medicine, 2022
BackgroundCardiac resynchronization therapy (CRT) is helpful in selected patients; however, responder rates rarely exceed 70%. Optimization of CRT may therefore benefit a large number of patients.
Hans Henrik Odland, Torbjørn Holm, Richard Cornelussen, Erik Kongsgård   +3 more
doaj   +1 more source

Zero-fluroscopy ablation for cardiac arrhythmias: A single-center experience in Mexico

Heart Vessels and Transplantation, 2023
Objective: Catheter ablation (CA) is a highly effective procedure for treating symptomatic tachyarrhythmias. However, the use of fluoroscopy, which is commonly employed in CA, exposes patients and medical personnel to ionizing radiation and its ...
Ulises Rojel-Martinez , Arturo Enriquez , Carlos De la Fuente , Oscar Sanchez-Parada , Ingrid Y. Lopez , Alejandro Rodriguez-Garza , Karla Bozada-Nolasco   +6 more
doaj   +1 more source

Improving osteoporosis treatment rates in inpatients admitted with hip fracture: A healthcare improvement initiative in a tertiary referral hospital

AGING MEDICINE, Volume 5, Issue 4, Page 264-271, December 2022., 2022
Our hospital introduced a standardized protocol for the treatment of osteoporosis in patients admitted for hip fracture. The aim of this article was to describe its implementation as well as assess the protocol's effect on treatment rates and safety. In our analysis, there was significant improvement in treatment rates with no instances of acute kidney
Andrew Gan Lin, Nargis Shaheen, Kirtan Ganda, John Cullen, Louise M. Waite, Markus J. Seibel   +5 more
wiley   +1 more source

PRRX1 Loss‐of‐Function Mutations Underlying Familial Atrial Fibrillation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Atrial fibrillation (AF) is the most common form of clinical cardiac dysrhythmia responsible for thromboembolic cerebral stroke, congestive heart failure, and death. Aggregating evidence highlights the strong genetic basis of AF. Nevertheless,
Xiao‐Juan Guo, Xing‐Biao Qiu, Jun Wang, Yu‐Han Guo, Chen‐Xi Yang, Li Li, Ri‐Feng Gao, Zun‐Ping Ke, Ruo‐Min Di, Yu‐Min Sun, Ying‐Jia Xu, Yi‐Qing Yang   +11 more
doaj   +1 more source

Drug-Induced Arrhythmias: A Scientific Statement From the American Heart Association.

Circulation, 2020
Many widely used medications may cause or exacerbate a variety of arrhythmias. Numerous antiarrhythmic agents, antimicrobial drugs, psychotropic medications, and methadone, as well as a growing list of drugs from other therapeutic classes (neurological ...
J. Tisdale, M. Chung, K. Campbell, M. Hammadah, J. Joglar, Jacinthe Leclerc, Bharath Rajagopalan   +6 more
semanticscholar   +1 more source

Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemia

American Journal of Hematology, Volume 98, Issue 2, Page 338-347, February 2023., 2023
Abstract Bruton tyrosine kinase (BTK) inhibitors have taken a central role in the management of patients with Waldenström macroglobulinemia and are the only agents approved by the Food and Drug Administration (FDA) to treat these patients. Although associated with high rates of durable responses, unmet needs with BTK inhibitor therapy include ...
Jorge J. Castillo, Christian Buske, Judith Trotman, Shayna Sarosiek, Steven P. Treon   +4 more
wiley   +1 more source

COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies

Journal of interventional cardiac electrophysiology, 2020
Background Cardiovascular and arrhythmic events have been reported in hospitalized COVID-19 patients. However, arrhythmia manifestations and treatment strategies used in these patients have not been well-described.
R. Gopinathannair, Faisal M. Merchant, Dhanunjaya R. Lakkireddy, S. Etheridge, Suzy Feigofsky, Janet K. Han, Rajesh Kabra, A. Natale, Stacy M. Poe, S. Saha, A. Russo   +10 more
semanticscholar   +1 more source

Further expansion and confirmation of phenotype in rare loss of YWHAE gene distinct from Miller–Dieker syndrome

American Journal of Medical Genetics Part A, Volume 191, Issue 2, Page 526-539, February 2023., 2023
Abstract Deletion of 17p13.3 has varying degrees of severity on brain development based on precise location and size of the deletion. The most severe phenotype is Miller–Dieker syndrome (MDS) which is characterized by lissencephaly, dysmorphic facial features, growth failure, developmental disability, and often early death.
Elizabeth K. Baker, Casey J. Brewer, Leonardo Ferreira, Mark Schapiro, Jeffrey Tenney, Heather M. Wied, Beth M. Kline‐Fath, Teresa A. Smolarek, K. Nicole Weaver, Robert J. Hopkin   +9 more
wiley   +1 more source

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

New England Journal of Medicine, 1997
BACKGROUND Patients who survive life-threatening ventricular arrhythmias are at risk for recurrent arrhythmias. They can be treated with either an implantable cardioverter-defibrillator or antiarrhythmic drugs, but the relative efficacy of these two ...
J. Mcanulty, B. Halperin, J. Kron, G. Larsen, M. Rait, R. Swenson, R. Floreck, C. Marchant, M. Hamlin, G. Heywood, P. Friedman, W. Stevenson, M. Swat, L. Ganz, M. Sweeney, J. Shea, J. Steinberg, F. Ehlert, S. Zelenkofstke, E. Menchavez-Tan, M. Stefano, G. Brown, L. Karagounis, B. Crandall, J. Osborn, D. Rawling, K. Summers, M. Jacobsen, J. Herre, R. Bernsteim, L. Klevan, D. Cannom, A. Bhandari, R. Lerman, B. Firth, R. Klein, R. Freedman, M. Marks, M. Delahunty, C. Spratt, R. Marinchak, S. Rials, P. Kowey, R. Fillart, M. Hernández, D. Scher, L. Zukerman, S. Farrell, J. Cross, J. Shewchjik, A. Epstein, R. Cooper, R. Dailey, S. M. Dailey, G. Kay, V. Plumb, R. Bubien, S. Knotts-Dolson, P. Mckenna, C. Tidwell, S. Kim, J. Fisher, K. Ferrick, J. Gross, U. Ben-Zur, J. Durkin, A. Ferrick, K. Beckman, J. McClelland, M. González, L. Widman, R. Lane, T. Deaton, J. Foster, G. Straughan, L. Wade, M. Brodsky, B. Allen, S. Ehrlich, L. Wolff, M. Macari-Hinson, J. Coromilas, T. Bigger, F. Livelli, J. Reiffel, K. Hickey, T. Akiyama, J. Daubert, C. Kim, D. Switzer, P. Pande, D. Flynn, M. Keller, C. Ocampo, K. Wahl, J. Vogt, S. Kutalek, S. Hessen, C. Movsowitz   +98 more
semanticscholar   +1 more source